CODIAK BIOSCIENCES INC (CDAK) Stock Analyst Earnings Estimates
NASDAQ:CDAK - Nasdaq - US1920101060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 390K | 2.92M 648.72% | 22.935M 685.45% | 27.589M 20.29% | 2.674M -90.31% | 2.394M -10.47% | 897.6K -62.51% | -100.00% | |
| EBITDA YoY % growth | -77.38M -111.19% | -86.56M -11.86% | -64.208M 25.82% | -50.678M 21.07% | -62.271M -22.88% | -77.741M -24.84% | N/A | N/A | |
| EBIT YoY % growth | -80.15M -108.89% | -90.92M -13.44% | -69.549M 23.51% | -51.347M 26.17% | -64.246M -25.12% | -79.538M -23.80% | -93.415M -17.45% | -110.798M -18.61% | |
| Operating Margin | -20,551.28% | -3,113.70% | -303.24% | -186.11% | -2,402.63% | -3,322.37% | -10,407.16% | N/A | |
| EPS YoY % growth | N/A | N/A | -3.21 83.10% | -1.89 41.06% | -1.25 33.83% | -0.96 23.15% | -0.86 10.95% | -0.92 -7.14% |
All data in USD
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.35 53.14% | -0.33 8.39% | -0.30 -0.87% | -0.30 49.86% | -0.24 29.41% | -0.27 19.59% | -0.28 8.99% | -0.28 6.90% | -0.28 -12.50% |
| Revenue Q2Q % growth | 691.897K -91.01% | 1.038M -91.83% | 1.038M -92.10% | 1.038M 98.85% | 1.798M 159.87% | 1.798M 73.22% | 1.798M 73.22% | 1.798M 73.22% | 1.798M |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.481M 6.97% | -16.014M -94.09% | -16.014M -128.22% | -16.524M 2.16% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.59 39.18% | -0.84 | 0.25 | 29.46% |
| Q2 2022 Q2Q % growth | -0.30 69.70% | -0.85 | 0.55 | 64.85% |
| Q1 2022 Q2Q % growth | -0.36 29.41% | -0.91 | 0.55 | 60.49% |
| Q4 2021 Q2Q % growth | -0.74 35.09% | -0.96 | 0.22 | 23.09% |
| Q3 2021 Q2Q % growth | -0.97 92.44% | -0.96 | -0.01 | -0.63% |
| Q2 2021 Q2Q % growth | -0.99 | -1.07 | 0.08 | 7.27% |
| Q1 2021 Q2Q % growth | -0.51 | -1.12 | 0.61 | 54.27% |
| Q4 2020 Q2Q % growth | -1.14 | -1.57 | 0.43 | 27.27% |
| Q3 2020 Q2Q % growth | -12.83 | -5.61 | -7.22 | -128.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 522K -54.88% | 599.423K | -77.423K | -12.92% |
| Q2 2022 Q2Q % growth | 13.145M 1,376.97% | 554.543K | 12.59M | 2,270.42% |
| Q1 2022 Q2Q % growth | 12.704M -3.68% | 4.284M | 8.42M | 196.55% |
| Q4 2021 Q2Q % growth | 7.697M 369.33% | 1.545M | 6.152M | 398.19% |
| Q3 2021 Q2Q % growth | 1.157M 21.79% | 1.464M | -307K | -20.97% |
| Q2 2021 Q2Q % growth | 890K 177.26% | 1.377M | -487K | -35.37% |
| Q1 2021 Q2Q % growth | 13.19M | 985.32K | 12.205M | 1,238.65% |
| Q4 2020 Q2Q % growth | 1.64M 993.33% | 534.48K | 1.106M | 206.84% |
| Q3 2020 Q2Q % growth | 950K 533.33% | 124.95K | 825.05K | 660.30% |
| Q2 2020 Q2Q % growth | 321K 256.67% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |